Lmr Partners LLP Biotechnology

Lmr Partners LLP

  • $9.66 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
VRTX
Vertex Pharmaceuticals Inc
PUT
$58.5 Million
145K
Q4 2024
New holding
ARGX
Argenx Se
CALL
$13.4 Million
21.8K
Q4 2024
Added 5.71%
NVO
Novo Nordisk A S
CALL
$10.3 Million
120K
Q4 2024
Reduced 60.65%
AXSM
Axsome Therapeutics, Inc.
CALL
$6.11 Million
72.2K
Q3 2020
Closed
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$5.47 Million
130K
Q2 2024
New holding
INSM
Insmed Inc
CALL
$5.18 Million
75K N/A
BBIO
Bridge Bio Pharma, Inc.
CALL
$3.94 Million
144K
Q4 2024
Reduced 48.08%
MRNA
Moderna, Inc.
PUT
$3.53 Million
85K
Q3 2024
Added 549.59%
UTHR
United Therapeutics Corp
PUT
$3.53 Million
10K
Q4 2022
Added 485.81%
BNTX
Bio N Tech Se
PUT
$2.85 Million
25K
Q4 2024
New holding
LQDA
Liquidia Corp
CALL
$2.35 Million
200K
Q2 2022
Closed
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$2.31 Million
7.5K
Q1 2024
Reduced 57.39%
VRNA
Verona Pharma PLC
CALL
$2.25 Million
48.5K N/A
NVAX
Novavax Inc
PUT
$2.22 Million
276K
Q3 2024
New holding
SMMT
Summit Therapeutics Inc.
PUT
$2.17 Million
122K
Q1 2023
New holding
CAPR
Capricor Therapeutics, Inc.
PUT
$2.1 Million
152K N/A
VKTX
Viking Therapeutics, Inc.
CALL
$2.01 Million
50K
Q4 2024
New holding
ARVN
Arvinas, Inc.
PUT
$1.92 Million
100K N/A
NVO
Novo Nordisk A S
PUT
$1.72 Million
20K
Q4 2024
Reduced 60.65%
IONS
Ionis Pharmaceuticals Inc
CALL
$1.51 Million
43.1K
Q1 2020
Closed
SAVA
Cassava Sciences Inc
PUT
$1.17 Million
495K
Q4 2024
New holding
SAVA
Cassava Sciences Inc
CALL
$1.16 Million
492K
Q4 2024
New holding
SRRK
Scholar Rock Holding Corp
CALL
$1.08 Million
25K
Q4 2024
New holding
MRNA
Moderna, Inc.
CALL
$873,000
21K
Q3 2024
Added 549.59%
CRVS
Corvus Pharmaceuticals, Inc.
PUT
$793,000
153K
Q3 2021
New holding
AKRO
Akero Therapeutics, Inc.
PUT
$695,000
25K
Q3 2024
Added 17.03%
BMRN
Biomarin Pharmaceutical Inc
PUT
$644,000
9.8K
Q4 2024
Reduced 94.12%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$617,000
2K
Q1 2024
Reduced 57.39%
ROIV
Roivant Sciences Ltd.
CALL
$591,000
50K
Q4 2024
Reduced 23.68%
KRYS
Krystal Biotech, Inc.
PUT
$391,000
2.5K
Q3 2024
New holding
AVXL
Anavex Life Sciences Corp.
PUT
$268,000
25K
Q3 2018
Closed
RVNC
Revance Therapeutics, Inc.
PUT
$256,000
100K
Q4 2024
Reduced 84.53%
IBRX
Immunity Bio, Inc.
PUT
$252,000
98.5K
Q4 2024
New holding
PRTA
Prothena Corp Public LTD CO
CALL
$249,000
18K N/A
AVXL
Anavex Life Sciences Corp.
CALL
$214,000
20K
Q3 2018
Closed
SANA
Sana Biotechnology, Inc.
PUT
$211,000
130K
Q4 2024
New holding
ANVS
Annovis Bio, Inc.
PUT
$149,000
29.7K N/A
GALT
Galectin Therapeutics Inc
PUT
$119,000
100K
Q3 2021
Closed
BDTX
Black Diamond Therapeutics, Inc.
PUT
$64,000
30.1K
Q4 2024
New holding
APLT
Applied Therapeutics Inc.
PUT
$61,000
72.3K
Q4 2024
New holding
INSM
Insmed Inc
PUT
$41,000
600 N/A
VRTX
Vertex Pharmaceuticals Inc
CALL
$40,000
100
Q4 2024
New holding
Filter Shares Options
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email